BIOMAT Database Logo BIOMAT Database Logo

Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients. 2023

Evidence-Based Complementary And Alternative Medicine

[This retracts the article DOI: 10.1155/2022/3478861.].

UI MeSH Term Description Entries

Related Publications

Evidence-Based Complementary And Alternative Medicine
Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
January 2022, Evidence-based complementary and alternative medicine : eCAM,
Evidence-Based Complementary And Alternative Medicine
[The prognostic value of cellular immunity function in patients with hepatocellular carcinoma].
March 2005, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Evidence-Based Complementary And Alternative Medicine
Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients.
April 2021, Hepatobiliary surgery and nutrition,
Evidence-Based Complementary And Alternative Medicine
Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma.
January 2020, BioMed research international,
Evidence-Based Complementary And Alternative Medicine
Prognostic Value of PLXND1 and TGF-β1 Coexpression and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma.
January 2020, Frontiers in oncology,
Evidence-Based Complementary And Alternative Medicine
The prognostic value of RHBDF2 in Pan-Cancer, and its correlation with cell Adhesion of Hepatocellular Carcinoma.
March 2023, Biotechnology & genetic engineering reviews,
Evidence-Based Complementary And Alternative Medicine
The Association of MUC16 Mutation with Tumor Mutation Burden and Its Prognostic Implications in Cutaneous Melanoma.
September 2020, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Evidence-Based Complementary And Alternative Medicine
Retracted: Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma.
January 2023, Contrast media & molecular imaging,
Evidence-Based Complementary And Alternative Medicine
Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma.
January 2021, Frontiers in genetics,
Evidence-Based Complementary And Alternative Medicine
Prognostic Value of PD-L1 in Patients with Hepatocellular Carcinoma.
May 2019, Clinical laboratory,
Copied contents to your clipboard!